Publications by authors named "Gideon Bahn"

Claim this Profile
H
Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes Trial.
Leah E Cahill, Rachel A Warren, Gideon D Bahn, Allie S Carew, Andrew P Levy

Am J Prev Cardiol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Serotonin 2A Receptor Autoantibodies Predict Rapid, Substantial Decline in Neurocognitive Performance in Older Adult Veterans with TBI.
Mark B Zimering, Mihal Grinberg, Catherine E Myers, Gideon Bahn

Endocrinol Diabetes Metab J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis.
Justin A Edward, Kevin Josey, Gideon Bahn, Liron Caplan, Jane E B Reusch

Cardiovasc Diabetol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generalizability of heterogeneous treatment effects based on causal forests applied to two randomized clinical trials of intensive glycemic control.
Sridharan Raghavan, Kevin Josey, Gideon Bahn, Domenic Reda, Sanjay Basu

Ann Epidemiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT).
Juraj Koska, Daniel S Nuyujukian, Gideon D Bahn, Jin J Zhou, Peter D Reaven

Cardiovasc Diabetol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eye Outcomes in Veteran Affairs Diabetes Trial (VADT) After 17 Years.
Nasrin Azad, Lily Agrawal, Gideon Bahn, Nicholas V Emanuele, Peter D Reaven

Diabetes Care· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT.
Jin J Zhou, Juraj Koska, Gideon Bahn, Peter Reaven

J Clin Endocrinol Metab· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood Pressure Variability and Risk of Heart Failure in ACCORD and the VADT.
Daniel S Nuyujukian, Juraj Koska, Gideon Bahn, Peter D Reaven, Jin J Zhou

Diabetes Care· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive Glycemic Control Improves Long-term Renal Outcomes in Type 2 Diabetes in the Veterans Affairs Diabetes Trial (VADT).
Lily Agrawal, Nasrin Azad, Gideon D Bahn, Peter D Reaven, Rodney A Hayward

Diabetes Care· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up.
Peter D Reaven, Nicholas V Emanuele, Wyndy L Wiitala, Gideon D Bahn, Domenic J Reda

N Engl J Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycaemic variation is a predictor of all-cause mortality in the Veteran Affairs Diabetes Trial.
Jin J Zhou, Juraj Koska, Gideon Bahn, Peter Reaven

Diab Vasc Dis Res· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 Diabetes Predicts Increased Risk of Neurodegenerative Complications in Veterans Suffering Traumatic Brain Injury.
Mark B Zimering, Deesha Patel, Gideon Bahn

J Endocrinol Diabetes· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial.
Jin J Zhou, Dawn C Schwenke, Gideon Bahn, Peter Reaven,

Diabetes Care· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes.
Juraj Koska, Aramesh Saremi, Scott Howell, Gideon Bahn, Barbora De Courten

Diabetes Care· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT).
Lily Agrawal, Nasrin Azad, Gideon D Bahn, Ling Ge, Peter D Reaven

Diabetologia· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study.
Aramesh Saremi, Scott Howell, Dawn C Schwenke, Gideon Bahn, Paul J Beisswenger

Diabetes Care· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Cognitive Decline in Older Adult Type 2 Diabetes from the Veterans Affairs Diabetes Trial.
Mark B Zimering, Jeffrey Knight, Ling Ge, Gideon Bahn,

Front Endocrinol (Lausanne)· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Blood Glucose Control and Lipids With Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT).
Nasrin Azad, Gideon D Bahn, Nicholas V Emanuele, Lily Agrawal, Ling Ge

Diabetes Care· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Link Between Hypoglycemia and Progression of Atherosclerosis in the Veterans Affairs Diabetes Trial (VADT).
Aramesh Saremi, Gideon D Bahn, Peter D Reaven,

Diabetes Care· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.
Rodney A Hayward, Peter D Reaven, Wyndy L Wiitala, Gideon D Bahn, Domenic J Reda

N Engl J Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of intensive glucose lowering therapy among major racial/ethnic groups in the Veterans Affairs Diabetes Trial.
Aramesh Saremi, Dawn C Schwenke, Gideon Bahn, Ling Ge, Nicholas Emanuele

Metabolism· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure and pulse pressure effects on renal outcomes in the Veterans Affairs Diabetes Trial (VADT).
Robert J Anderson, Gideon D Bahn, Nicholas V Emanuele, Jennifer B Marks, William C Duckworth

Diabetes Care· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of blood glucose control and pancreatic reserve with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT).
Nasrin Azad, Lily Agrawal, Nicholas V Emanuele, Ronald Klein, Gideon D Bahn

Diabetologia· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT).
Nasrin Azad, Lily Agrawal, Nicholas V Emanuele, Ronald Klein, Gideon D Bahn

Diabetes Care· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of intensive glucose lowering on lipoprotein particle profiles and inflammatory markers in the Veterans Affairs Diabetes Trial (VADT).
Juraj Koska, Aramesh Saremi, Gideon Bahn, Shizuya Yamashita, Peter D Reaven

Diabetes Care· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis